Synthetic Biology Platform

Synthetic Biology Platform: Next-Generation Cellular Engineering

GenomeFrontier has established the Synthetic Biology Platform to create novel genetic components, which can be incorporated into large multiplex transgenes via GTailor™ for the re-engineering of human cells. By leveraging a systematic and modular approach, GenomeFrontier makes biological engineering efficient, predictable, and reliable.

Through the Synthetic Biology Platform, we drive the development of next-generation gene therapies across broad clinical fronts:

• Next-Generation Cell Therapies
• Advanced Gene and Protein-Based Interventions
• Novel Clinical Applications

 

This systematic and modular approach ensures the scalable and reliable manufacturing of advanced cellular therapeutics.

Figure 1. The Synthetic Biology Platform yields modular biological components that can facilitate cell re-engineering to create next-generation gene therapies. The tools produced in the Synthetic Biology Platform have functions related to genetic modification, gene expression control, and protein expression and function.